Topic

PNB-001 (GPP-BALACOVIN)

1 article

PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod
COVID-19 24 Jun 2021

PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod

PNB 001/ GPP-BALACOVIN is proving to be a breakthrough in COVID-19 treatment  Kerala-based PNB Vesper has received DCGI permission to…